Recent advancements in technology and methodologies are opening new avenues in protein targeting. Techniques such as cryo-electron microscopy and mass spectrometry are providing detailed insights into protein structures, facilitating the design of more effective inhibitors. Additionally, the development of personalized medicine approaches, where treatments are tailored based on the genetic makeup of the pathogen and the host, holds promise for more effective and targeted therapies.
